Evidence map›Paper›PMID 39663454›Full record

ArticleNature2025

Central control of dynamic gene circuits governs T cell rest and activation.

Maya M Arce, Jennifer M Umhoefer, Nadia Arang, Sivakanthan Kasinathan, Jacob W Freimer, Zachary Steinhart, Haolin Shen, Minh T N Pham, Mineto Ota, Anika Wadhera and 13 more

Abstract read
In one paragraph

Article in Nature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. A unified genetic perturbation language for human cellular programming.bioRxiv : the preprint server for biology · 2025
    Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Maya M ArceGladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.
Jennifer M UmhoeferGladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.ORCID 0000-0002-8563-9641
Nadia ArangQuantitative Biosciences Institute (QBI), University of California, San Francisco, CA, USA.
Sivakanthan KasinathanGladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.ORCID 0000-0003-2218-6371
Jacob W FreimerGladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.ORCID 0000-0001-9239-2272
Zachary SteinhartGladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.
Haolin ShenBiomedical Sciences graduate program, University of California, San Francisco, CA, USA.ORCID 0000-0003-1550-2831
Minh T N PhamDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Mineto OtaGladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.ORCID 0000-0003-4552-8573
Anika WadheraGladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.ORCID 0009-0009-4694-6129
Rama DajaniGladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.
Dmytro DorovskyiGladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.ORCID 0009-0007-4297-2958
Yan Yi ChenGladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.
Qi LiuGladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.
Yuan ZhouQuantitative Biosciences Institute (QBI), University of California, San Francisco, CA, USA.ORCID 0000-0002-1393-5476
Danielle L SwaneyQuantitative Biosciences Institute (QBI), University of California, San Francisco, CA, USA.ORCID 0000-0001-6119-6084
Kirsten ObernierQuantitative Biosciences Institute (QBI), University of California, San Francisco, CA, USA.ORCID 0000-0002-4025-1299
Brian R ShyGladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.ORCID 0000-0001-9569-3708
Julia CarnevaleGladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.ORCID 0000-0001-9410-7148
Ansuman T SatpathyGladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.ORCID 0000-0002-5167-537X
Nevan J KroganQuantitative Biosciences Institute (QBI), University of California, San Francisco, CA, USA.ORCID 0000-0003-4902-337X
Jonathan K PritchardDepartment of Genetics, Stanford University, Stanford, CA, USA.ORCID 0000-0002-8828-5236
Alexander MarsonGladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA. alex.marson@gladstone.ucsf.edu.

Funding

The Cancer Cell Map Initiative v2.0U54CA274502 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Emma Lundberg · 2022 to 2026
$14.2M
MOLECULAR AND CELLULAR IMMUNOLOGYT32AI007334 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CYSTER, JASON G · 1988 to 2023
$11.0M
Integration of genetic association mapping and functional data to elucidate genetic mechanisms of diseaseR01HG008140 · NHGRI · STANFORD UNIVERSITY · PI JONATHAN K PRITCHARD · 2016 to 2026
$7.3M
Training Program in Adult and Pediatric RheumatologyT32AR050942 · NIAMS · STANFORD UNIVERSITY · PI LEWIS, DAVID BRAM, ROBINSON, WILLIAM H · 2005 to 2025
$6.6M
Restorative practice in repairing harm and promoting safe and inclusive practices in the laboratory.T32GM136547 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Adrian Erlebacher, Anita Sil · 2020 to 2026
$4.5M
4DN Interrogation of T Cell Exhaustion in CancerU01CA260852 · NCI · STANFORD UNIVERSITY · PI SATPATHY, ANSUMAN · 2020 to 2024
$2.6M
Targeting SOCS1 and RASA2 to Engineer More Potent Adoptive T Cell Therapies for Cancer Treatment.K08CA252605 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CARNEVALE, JULIA C · 2020 to 2024
$1.3M
Non-viral genome, epigenome, and transcriptome engineering for clinical CAR-T cell manufacturingK08CA273529 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Brian R Shy · 2022 to 2026
$1.2M
BD FACSAria II Flow CytometerS10RR028962 · NCRR · J. DAVID GLADSTONE INSTITUTES · PI CAVROIS, MARIELLE · 2011 to 2011
$544k
Acquisition of Covaris E220 and Sciclone G3 systems for high throughput sequencinS10OD010786 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI COMAI, LUCA · 2012 to 2012
$311k
NCATS NIH HHS L30 TR002983NCI NIH HHS K08 CA252605NCI NIH HHS K08 CA273529NCI NIH HHS U01 CA260852NCI NIH HHS U54 CA274502NCRR NIH HHS S10 RR028962NHGRI NIH HHS R01 HG008140NIAID NIH HHS T32 AI007334NIAMS NIH HHS T32 AR050942NIGMS NIH HHS T32 GM136547NIH HHS S10 OD010786
6 · The paper itself

Abstract

The ability of cells to maintain distinct identities and respond to transient environmental signals requires tightly controlled regulation of gene networks

Indexed as

CD4-Positive T-LymphocytesGene Expression RegulationGene Regulatory NetworksLymphocyte ActivationCRISPR-Cas SystemsHistonesHumansMediator ComplexMethylationProto-Oncogene Proteins c-mycSingle-Cell AnalysisT-LymphocytesT-Lymphocytes, RegulatoryHistonesMediator ComplexProto-Oncogene Proteins c-myc

Identifiers

PMID39663454
PMCPMC11754113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.